Cannabix Technologies delivers Marijuana Breath Test Hardware to Omega Laboratories Inc.
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...
Year: 2025
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio...
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company...
Walking Alone at Night is the Greatest Safety Fear of Women Nationwide — Almost Half Say Safety Concerns Limit Daily Activities LogicMark Poll Reveals
More women turn to technology solutions, with 71% looking to discreet devices for safetyLOUISVILLE, Ky., Aug. 19, 2025 (GLOBE NEWSWIRE)...
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
Call Scheduled for today, Tuesday, August 19, 2025, at 5:00 pm ETLITTLETON, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Vivos...
BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on...
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led...
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug....
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
SPC-15’s intranasal spray formulation meets safety standards for clinical trial development SARASOTA, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Silo...
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced...
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class...
Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
NEW YORK and CAMBRIDGE, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation...
COUR Pharma Doses First Patient in Clinical Trial Evaluating CNP-103 in People Recently Diagnosed with Type 1 Diabetes
CHICAGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies to treat autoimmune...
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
UNIONDALE, NY, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation...
Aptitude Development Expands Partnership with Counslr to Offer 24/7 Mental Health Support Across All Properties Nationwide
Unlimited, 24/7 text-based mental health support available to student residents as demand for wellness amenities grows Student Housing Wellness Amenities...
BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic’s IzoView Device
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB:...
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
BOSTON and ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical...
Milestone® Pharmaceuticals to Present at Upcoming Conferences
MONTREAL and CHARLOTTE, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced President and CEO, Joe...
ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed...
Custom Health Acquires PatchRx to Expand Patient Connected Care Platform
Integration of PatchRx's adherence technology and connected dispensing strengthens Custom Health's vertically integrated, data-driven medication management for patients, providers, and...